SCHEMBL24975772

SCHEMBL24975772

COc1ccc(CN2[C@H](C)[C@H](NC(=O)OC(C)(C)C)C[C@@H]2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.47
KMT2A Q03164 1/20 0.47
CYP3A4 P08684 1/20 0.43
KDM1A O60341 1/20 0.43
CXCR4 P61073 1/20 0.40
ALDH1A1 P00352 4/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
LTA4H P09960 1/20 0.39
HPGD P15428 1/20 0.39
CACNA1B Q00975 1/20 0.39
LMNA P02545 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
CACNA1H O95180 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24975769 0.81 L3MBTL1 (0.53) L3MBTL1KMT2ACYP3A4KDM1ACXCR4
SCHEMBL24976021 0.81 L3MBTL1 (0.53) L3MBTL1KMT2ACYP3A4KDM1ACXCR4
SCHEMBL24977220 0.81 L3MBTL1 (0.53) L3MBTL1KMT2ACYP3A4KDM1ACXCR4
SCHEMBL25841821 0.76 KMT2A (0.50) L3MBTL1KMT2AALDH1A1CYP2D6CYP2C19
SCHEMBL7475783 0.74 SIGMAR1 (0.65) KMT2AALDH1A1SIGMAR1
SCHEMBL20781142 0.73 CYP3A4 (0.46) L3MBTL1KMT2ACYP3A4CXCR4ALDH1A1
SCHEMBL20773434 0.73 CYP3A4 (0.46) L3MBTL1KMT2ACYP3A4CXCR4ALDH1A1
SCHEMBL25530099 0.73 CYP3A4 (0.46) L3MBTL1KMT2ACYP3A4CXCR4ALDH1A1
SCHEMBL25530138 0.73 CYP3A4 (0.46) L3MBTL1KMT2ACYP3A4CXCR4ALDH1A1
SCHEMBL25530141 0.73 CYP3A4 (0.46) L3MBTL1KMT2ACYP3A4CXCR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof AMGEN INC. (US) 2023-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof CYP3A7, CYP51A1, NT5C3B L3MBTL1 4695/4885KMT2A 2971/4885CYP3A4 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.